The abstract is read at the publisher; the summary is JClub's.
Single-cell RNA sequencing of hundreds of thousands of individually infected asynchronous red blood cells shows artemisinin, atovaquone, and ganaplacide each generate distinct parasite cell populations with different transcriptional profiles.
- Why it matters: Mechanisms of action and drug-evading responses in malaria parasites are difficult to resolve, and existing gene-network work has been used less to characterize how parasites respond to drug treatment across life-cycle stages.
- What they did: The study applied scRNA-seq to individually infected asynchronous red blood cells treated with artemisinin, atovaquone, or ganaplacide, then compared single-cell transcription patterns to previously observed synchronized-cell profiles using a new analytical pipeline.
- The result: Artemisinin enriched gametocyte-associated gene expression, while atovaquone and ganaplacide showed fewer life-cycle perturbations; bulk analysis linked atovaquone to pyrimidine biosynthesis transcripts, enabling drug-class profiling and MOA deconvolution.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.